VANGUARD GROUP INC 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-10 1:14 pm Purchase |
2024-06-28 | 13G | Krystal Biotech, Inc. KRYS |
VANGUARD GROUP INC | 2,869,136 10.050% |
433,362 (+17.79%) |
Filing |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Krystal Biotech, Inc. KRYS |
VANGUARD GROUP INC | 2,435,774 8.640% |
2,435,774 (New Position) |
Filing |